Jason Cole Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Cole.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason Cole. Jason Cole is EVP,Corp Dev & General Counsel in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and SVP & General Counsel in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
Latest Insider Trading Transactions of Jason Cole
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 07 2013 | CRXX | EPIRUS Biopharmace ... | Cole Jason | EVP,Corp Dev & Gene ... | Option Exercise | A | 0.76 | 280,000 | 212,800 | 280,000 | |
| Jan 31 2012 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Sell | S | 1.09 | 2,420 | 2,638 | 15,086 | 17.5 K to 15.1 K (-13.82 %) |
| Jan 27 2012 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | A | 1.13 | 242,809 | 274,374 | 242,809 | |
| Jan 27 2012 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | A | 1.13 | 107,191 | 121,126 | 107,191 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 0.95 | 54,687 | 51,953 | 240,626 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 18,510 | 19,806 | 23,799 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 5,784 | 6,189 | 1,954 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 1,117 | 1,195 | 0 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 3,348 | 3,582 | 5,023 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 42,188 | 45,141 | 32,813 | |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Sell | S | 2.70 | 54,687 | 147,655 | 11,256 | 65.9 K to 11.3 K (-82.93 %) |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Buy | M | 0.95 | 54,687 | 51,953 | 65,943 | 11.3 K to 65.9 K (+485.85 %) |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Sell | S | 2.70 | 70,947 | 191,557 | 11,256 | 82.2 K to 11.3 K (-86.31 %) |
| Jul 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Buy | M | 1.07 | 70,947 | 75,913 | 82,203 | 11.3 K to 82.2 K (+630.30 %) |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 0.95 | 54,687 | 51,953 | 295,313 | |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 75 | 80 | 7,738 | |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 4,837 | 5,176 | 1,117 | |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 18,416 | 19,705 | 8,371 | |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | M | 1.07 | 47,620 | 50,953 | 0 | |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Sell | S | 2.33 | 54,687 | 127,421 | 11,256 | 65.9 K to 11.3 K (-82.93 %) |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Buy | M | 0.95 | 54,687 | 51,953 | 65,943 | 11.3 K to 65.9 K (+485.85 %) |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Sell | S | 2.33 | 70,948 | 165,309 | 11,256 | 82.2 K to 11.3 K (-86.31 %) |
| Jun 13 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Buy | M | 1.07 | 70,948 | 75,914 | 82,204 | 11.3 K to 82.2 K (+630.31 %) |
| Feb 10 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Option Exercise | A | 2.65 | 100,000 | 265,000 | 100,000 | |
| Jan 28 2011 | CRXX | EPIRUS Biopharmace ... | Cole Jason | SVP & General Couns ... | Sell | S | 2.03 | 2,319 | 4,708 | 17,506 | 19.8 K to 17.5 K (-11.70 %) |
Page: 1